3M WP
Innovent Biologics begins subject dosing in plaque psoriasis therapy trial
The trial will assess the safety and efficacy of picankibart in moderate-to-severe plaque psoriasis patients.
The trial will assess the safety and efficacy of picankibart in moderate-to-severe plaque psoriasis patients.